Targeting PI3K in Cancer: Impact on Tumor Cells, Their Protective Stroma, Angiogenesis, and Immunotherapy

Cancer Discovery - United States
doi 10.1158/2159-8290.cd-16-0716
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

In Silico Modeling of Immunotherapy and Stroma-Targeting Therapies in Human Colorectal Cancer

Cancer Research
Cancer ResearchOncology
2017English

Targeting Treg Cells in Cancer Immunotherapy

European Journal of Immunology
AllergyImmunology
2019English

Targeting Natural Killer Cells for Tumor Immunotherapy

Frontiers in Immunology
AllergyImmunology
2020English

Targeting the Tumor Microenvironment: Focus on Angiogenesis

Journal of Oncology
Oncology
2012English

Improving Cancer Immunotherapy by Targeting Tumor-Induced Immune Suppression

Cancer and Metastasis Reviews
Cancer ResearchOncology
2011English

The Impact of PI3K Inhibitors on Breast Cancer Cell and Its Tumor Microenvironment

PeerJ
GeneticsMolecular BiologyBiochemistryBiological SciencesMedicineAgriculturalNeuroscience
2018English

Targeting Gas6/Tam in Cancer Cells and Tumor Microenvironment

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2018English

MiR-199b-5p Suppresses Tumor Angiogenesis Mediated by Vascular Endothelial Cells in Breast Cancer by Targeting ALK1

Frontiers in Genetics
GeneticsMolecular Medicine
2020English

Targeting Cancer Stem Cells With Natural Killer Cell Immunotherapy

Expert Opinion on Biological Therapy
Drug DiscoveryClinical BiochemistryPharmacology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy